SLS — SELLAS Life Sciences Group, Inc. - Common Stock
Session close: $17.95. Regular-session share volume: 33,532,534. Change from previous close: -6.27%.
Key developments
Offsetting that, SELLAS commenced an underwritten public offering of common stock, with underwriters granted an option for additional shares and J.P. Morgan and TD Cowen as joint book-running managers. The offering is subject to market conditions with no assurance of final size or completion, and the stock fell in after-hours trading following the announcement.
Company mentioned — Mentions SLS in the article text. SELLAS Life Sciences Commences $150 Million Public Offering of Common Stock · Company mentioned — Mentions SLS in the article text. Sellas Life Sciences stock falls on $150M stock offering · Company mentioned — Mentions SLS in the article text. SELLAS Life Sciences Announces Proposed $150.0 Million Underwritten Public Offering